KBC Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,736
| Closed | -$18K | – | 1869 |
|
|
2023
Q3 | $18K | Sell |
4,736
-763
| -14% | -$2.9K | ﹤0.01% | 1891 |
|
|
2023
Q2 | $23K | Hold |
5,499
| – | – | ﹤0.01% | 1461 |
|
|
2023
Q1 | $38K | Hold |
5,499
| – | – | ﹤0.01% | 1434 |
|
|
2022
Q4 | $44K | Hold |
5,499
| – | – | ﹤0.01% | 1418 |
|
|
2022
Q3 | $53K | Hold |
5,499
| – | – | ﹤0.01% | 1378 |
|
|
2022
Q2 | $40K | Buy |
+5,499
| New | +$40K | ﹤0.01% | 1458 |
|
|
2022
Q1 | – | Sell |
-35,429
| Closed | -$565K | – | 1269 |
|
|
2021
Q4 | $565K | Sell |
35,429
-1,521
| -4% | -$24.3K | ﹤0.01% | 837 |
|
|
2021
Q3 | $594K | Sell |
36,950
-37,776
| -51% | -$607K | ﹤0.01% | 831 |
|
|
2021
Q2 | $1.03M | Buy |
74,726
+10,594
| +17% | +$147K | ﹤0.01% | 873 |
|
|
2021
Q1 | $936K | Buy |
+64,132
| New | +$936K | ﹤0.01% | 890 |
|
|
2020
Q4 | – | Sell |
-61,168
| Closed | -$1.12M | – | 1267 |
|
|
2020
Q3 | $1.12M | Hold |
61,168
| – | – | ﹤0.01% | 793 |
|
|
2020
Q2 | $1.09M | Buy |
+61,168
| New | +$1.09M | ﹤0.01% | 806 |
|